470 related articles for article (PubMed ID: 12782602)
21. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
22. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
23. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.
Quadros MR; Peruzzi F; Kari C; Rodeck U
Cancer Res; 2004 Jun; 64(11):3934-9. PubMed ID: 15173005
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
[TBL] [Abstract][Full Text] [Related]
25. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
[TBL] [Abstract][Full Text] [Related]
26. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
27. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
[TBL] [Abstract][Full Text] [Related]
28. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
29. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
30. Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK.
Zhao L; Hart S; Cheng J; Melenhorst JJ; Bierie B; Ernst M; Stewart C; Schaper F; Heinrich PC; Ullrich A; Robinson GW; Hennighausen L
J Biol Chem; 2004 Oct; 279(42):44093-100. PubMed ID: 15292206
[TBL] [Abstract][Full Text] [Related]
31. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
[TBL] [Abstract][Full Text] [Related]
32. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
33. Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas.
Rawat R; Rainey GJ; Thompson CD; Frazier-Jessen MR; Brown RT; Nordan RP
Blood; 2000 Nov; 96(10):3514-21. PubMed ID: 11071649
[TBL] [Abstract][Full Text] [Related]
34. Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma.
Burger R; Guenther A; Bakker F; Schmalzing M; Bernand S; Baum W; Duerr B; Hocke GM; Steininger H; Gebhart E; Gramatzki M
Hematol J; 2001; 2(1):42-53. PubMed ID: 11920233
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
36. Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.
Steinman RA; Wentzel A; Lu Y; Stehle C; Grandis JR
Oncogene; 2003 Jun; 22(23):3608-15. PubMed ID: 12789269
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
[TBL] [Abstract][Full Text] [Related]
38. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
40. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
French JD; Tschumper RC; Jelinek DF
Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]